Dashboard
Manage Tickers

BNTXBioNTech SE

Nasdaq biontech.de


$ 92.24 $ -0.44 (-0.47 %)    

Tuesday, 14-May-2024 15:59:00 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 445.88 $ 2.85 (0.64 %)
DIA $ 395.58 $ 1.12 (0.28 %)
SPY $ 523.16 $ 2.39 (0.46 %)
TLT $ 90.86 $ 0.51 (0.56 %)
GLD $ 218.12 $ 1.83 (0.85 %)
$ 92.28
$ 92.68
$ 0.00 x 0
$ 0.00 x 0
$ 91.81 - $ 92.93
$ 85.21 - $ 125.83
271,663
na
21.94M
$ 0.08
$ 0.02
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

evercore-isi-group-initiates-coverage-on-biontech-with-in-line-rating-announces-price-target-of-100
Evercore ISI Group Initiates Coverage On B...
05/14/2024 09:10:02

Evercore ISI Group analyst Cory Kasimov initiates coverage on BioNTech (NASDAQ:BNTX) with a In-Line rating and announces Pri...

elon-musk-breaks-ranks-with-gop-by-praising-genetic-engineering-tech-that-helped-fight-covid-19-digital-medicine-with-incredible-potential
Elon Musk Breaks Ranks With GOP By Praisin...
05/09/2024 09:01:47

Elon Musk has come off as a flagbearer of the mRNA technology, which is seen holding out a lot of promise by scientists.

hc-wainwright--co-maintains-buy-on-biontech-raises-price-target-to-113
HC Wainwright & Co. Maintains Buy on BioNT...
05/08/2024 11:20:35

HC Wainwright & Co. analyst Robert Burns maintains BioNTech (NASDAQ:BNTX) with a Buy and raises the price target from $1...

cracking-the-code-understanding-analyst-reviews-for-biontech
Cracking The Code: Understanding Analyst R...
05/07/2024 18:01:15

td-cowen-maintains-hold-on-biontech-raises-price-target-to-98
TD Cowen Maintains Hold on BioNTech, Raise...
05/07/2024 16:48:02

TD Cowen analyst Yaron Werber maintains BioNTech (NASDAQ:BNTX) with a Hold and raises the price target from $95 to $98.

bmo-capital-maintains-outperform-on-biontech-lowers-price-target-to-122
BMO Capital Maintains Outperform on BioNTe...
05/07/2024 15:35:51

BMO Capital analyst Etzer Darout maintains BioNTech (NASDAQ:BNTX) with a Outperform and lowers the price target from $123 to...

whats-going-with-biontech-stock-on-monday
What's Going With BioNTech Stock On Monday?
05/06/2024 14:02:06

BioNTech reports Q1 loss, missing revenue expectations. Despite challenges, BioNTech aims for significant growth, fueled by inn...

biontech-reports-downbeat-earnings-joins-medical-properties-trust-and-other-big-stocks-moving-lower-in-mondays-pre-market-session
BioNTech Reports Downbeat Earnings, Joins ...
05/06/2024 11:32:06

wall-street-looks-to-extend-rally-amid-caution-over-fed-speeches-more-earnings-why-this-analyst-thinks-bull-market-is-still-quite-young
Wall Street Looks To Extend Rally Amid Cau...
05/06/2024 11:09:17

U.S. stocks are likely to extend their gains as major index futures are modestly higher on Monday. Strong earnings reports cont...

biontech-reaffirms-2024-revenue-guidance-of-25b-31b
BioNTech Reaffirms 2024 Revenue Guidance O...
05/06/2024 10:54:23

Planned 2024 Financial Year Expenses and Capex R&D expenses: €2.4B-€2.6B SG&A expenses: €700M-€800M Capital expend...

biontech-q1-2024-gaap-eps-131-misses-097-estimate-sales-187600m-miss-427500m-estimate
BioNTech Q1 2024 GAAP EPS €(1.31) Misses €...
05/06/2024 10:51:06

will-earnings-cheer-continue-this-week-all-eyes-on-disney-palantir-robinhood-while-reddit-gears-up-for-debut-quarterly-report
Will Earnings Cheer Continue This Week? Al...
05/06/2024 09:25:15

According to FactSet, a financial data analytics firm, 80% of S&P 500 companies have reported earnings so far.

gsk-sees-strong-demand-for-vaccines-and-asthma-drugs-raises-annual-outlook
GSK Sees Strong Demand For Vaccines and As...
05/01/2024 13:42:17

Discover GSK's first-quarter performance, boasting a 10% Y/Y sales surge to £7.4 billion. Notable growth in Vaccines and Sp...

covid-19-patent-dispute-sorted-acuitas-therapeutics-and-curevac-reach-settlement-in-patent-battle
COVID-19 Patent Dispute Sorted: Acuitas Th...
04/26/2024 18:45:00

Acuitas Therapeutics settles lawsuit with CureVac over COVID-19 vaccine patents. Legal disputes unfold among biotech giants Pfi...

whats-going-on-with-pfizer-stock-on-thursday
What's Going On With Pfizer Stock On Thurs...
04/25/2024 17:51:32

GSK initiates legal proceedings against Pfizer and BioNTech over alleged COVID-19 vaccine patent infringement, intensifying hig...

moderna-faces-pfizer-biontech-in-london-patent-battle-over-covid-19-vaccines-in-legal-showdown
Moderna Faces Pfizer, BioNTech in London P...
04/23/2024 19:00:34

Moderna challenges Pfizer and BioNTech in a London patent trial over mRNA vaccine patents. The outcome may reshape the pharmace...

assessing-biontech-insights-from-11-financial-analysts
Assessing BioNTech: Insights From 11 Finan...
04/17/2024 14:00:53

hc-wainwright--co-reiterates-buy-on-biontech-maintains-107-price-target
HC Wainwright & Co. Reiterates Buy on BioN...
04/17/2024 10:24:03

HC Wainwright & Co. analyst Robert Burns reiterates BioNTech (NASDAQ:BNTX) with a Buy and maintains $107 price target.

reported-sunday-biontech-three-year-phase-1-follow-up-data-for-mrna-based-individualized-immunotherapy-candidate-shows-persistence-of-immune-response-and-delayed-tumor-recurrence-in-some-patients-with-resected-pancreatic-cancer
Reported Sunday, BioNTech Three-Year Phase...
04/08/2024 06:45:52

Three-year follow-up data of an investigator-initiated Phase 1 trial of the individualized mRNA cancer vaccine candidate auto...

curevac-gsk-partner-release-data-on-influenza-vaccine-study
CureVac, GSK Partner Release Data On Influ...
04/04/2024 16:18:36

CureVac reveals Phase 2 interim data for its seasonal influenza vaccine in collaboration with GSK. Results show broad antigen c...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION